![]() | Up a level |
Number of items: 1.
Horne, GA, Stobo, J, Kelly, C, Mukhopadhyay, A, Latif, AL, Dixon-Hughes, J, McMahon, L, Cony-Makhoul, P, Byrne, J, Smith, G et al (show 13 more authors)
(2020)
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.
LEUKEMIA, 34 (7).
pp. 1775-1786.